ArticleOrphanet journal of rare diseases2021

A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study).

Fernando de Andrés-Nogales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.